- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Letermovir tablets are an antiviral drug mainly used to prevent cytomegalovirus (CMV) infection, particularly suitable for high-risk patients ...
The medication precautions for Ixazomib involve various aspects such as hematological toxicity, liver and kidney function monitoring, and infec...
Gilteritinib, as an FLT3 inhibitor, has significant efficacy in patients with relapsed/refractory acute myeloid leukemia (AML) carrying FLT3 mu...
The standard dose of Gilteritinib is 120mg orally once daily, usually taken as a single 120mg tablet on an empty stomach. The specific dosage m...
Acalabrutinib, as a BTK inhibitor, should be scheduled according to the indications and individual patient conditions. It is usually administer...
Acalabrutinib, as a BTK inhibitor, should be used with a focus on bleeding risk, infection prevention and control, and medication safety for sp...
The relationship between the administration time and diet of Acalabrutinib needs to be comprehensively considered based on the characteristics ...
Acalabrutinib, as a BTK inhibitor, has a different onset time due to individual differences and disease types. It usually requires continuous ...
The daily dosage of Selinexor should be calculated based on the dosage form specifications and prescription dosage, and the specific dosage sho...
Selinexor, as a novel nuclear export inhibitor, is mainly effective in the treatment of recurrent/refractory hematological tumors, demonstratin...
